Alkylating antineoplastic agent

An alkylating antineoplastic agent is an alkylating agent used in cancer treatment that attaches an alkyl group (CnH2n+1) to DNA.[1]
With succeeding generations of tumor cells  the differentiation is typically lost and growth become less regulated  and tumors become less responsive to most chemotherapeutic agents  Objectives of Chemotherapy There are few kinds of strategies in the admi
like invasion and metastasis  Metastasis is the spread of a cancer from one organ or part to another non adjacent organ or part  Invasion is the spread of a cancer to another adjacent organ  Mechanism of action of chemotherapy Chemotherapeutic drugs damag
which are the building blocks of DNA  They prevent these substances becoming incorporated in to DNA during S phase of the cell cycle and thus stopping normal development and division  Anthracycline Antrhacycline inhibits DNA and RNA synthesis by intercala
Source: http://en.wikipedia.org/wiki/Alkylating_antineoplastic_agent

From Wikipedia, the free encyclopedia

Jump to: navigation, search

An alkylating antineoplastic agent is an alkylating agent used in cancer treatment that attaches an alkyl group (CnH2n+1) to DNA.[1]

The alkyl group is attached to the guanine base of DNA, at the number 7 nitrogen atom of the imidazole ring.

Since cancer cells, in general, proliferate faster and with less error-correcting than healthy cells, cancer cells are more sensitive to DNA damage — such as being alkylated. Alkylating agents are used to treat several cancers. However, they are also toxic to normal cells (cytotoxic), leading to damage, in particular in cells that divide frequently, as those in the gastrointestinal tract, bone marrow, and ovaries, which can cause loss of fertility. Alkylating agents are also carcinogenic. Hyperthermia is especially effective at enhancing the effects of alkylating agents.[2]

Contents

  • 1 History
  • 2 Agents acting nonspecifically
  • 3 Agents require activation
  • 4 Dialkylating agents, limpet attachment, and monoalkylating agents
  • 5 Examples
    • 5.1 Classical alkylating agents
    • 5.2 Alkylating-like
    • 5.3 Nonclassical
  • 6 References
  • 7 External links

History

Before their use in chemotherapy, alkylating agents were better known for the use of sulfur mustard ("mustard gas") and related chemical weapons in World War I. In general, these were not used in World War II, but, in a lone exception, the United States Liberty Ship John Harvey carried a cache of the weapons that were released during the Air Raid on Bari in 1943, causing casualties to hundreds of sailors and Italian civilians. Medical tests of affected personnel revealed a profound bone marrow and lymphoid aplasia. Nitrogen mustard was subsequently recommended for testing in humans by Goodman and Gilman at Yale. Because of secrecy surrounding the war gas program, the results were not published until 1946,[3] but revealed a striking but temporary dissolution of tumor masses. Even so, it was not until 1963 that further studies of the drug began to impact patients.[4]

Agents acting nonspecifically

Some alkylating agents are active under conditions present in cells; and the same mechanism that makes them toxic allows them to be used as anti-cancer drugs. They stop tumor growth by crosslinking guanine nucleobases in DNA double-helix strands, directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. These drugs act nonspecifically.

Agents require activation

Some of them require conversion into active substances in vivo (e.g., cyclophosphamide).

Cyclophosphamide is one of the most potent immunosuppressive substances. In small dosages, it is very efficient in the therapy of systemic lupus erythematosus, autoimmune hemolytic anemias, Wegener's granulomatosis, and other autoimmune diseases. High dosages cause pancytopenia and hemorrhagic cystitis.

Dialkylating agents, limpet attachment, and monoalkylating agents

Dialkylating agents can react with two different 7-N-guanine residues, and, if these are in different strands of DNA, the result is cross-linkage of the DNA strands, which prevents uncoiling of the DNA double helix. If the two guanine residues are in the same strand, the result is called limpet attachment of the drug molecule to the DNA.

Monoalkylating agents can react only with one 7-N of guanine.

Limpet attachment and monoalkylation do not prevent the separation of the two DNA strands of the double helix but do prevent vital DNA-processing enzymes from accessing the DNA. The final result is inhibition of cell growth or stimulation of apoptosis, cell suicide.

Examples

In the Anatomical Therapeutic Chemical Classification System, alkylating agents are classified under L01A.

Classical alkylating agents

Many of the agents are known as "Classical alkylating agents". These include true alkyl groups, and have been known for a longer time than some of the other alkylating agents. Examples include melphalan and chlorambucil.[5]

The following three groups are almost always considered "classical".

Thiotepa and its analogues are usually considered classical, but can be considered nonclassical.

Alkylating-like

Platinum-based chemotherapeutic drugs (termed platinum analogues) act in a similar manner. These agents do not have an alkyl group, but nevertheless damage DNA.[7] They permanently coordinate to DNA to interfere with DNA repair, so they are sometimes described as "alkylating-like".

These agents also bind at N7 of guanine.

Nonclassical

Certain alkylating agents are sometimes described as "nonclassical". There is not a perfect consensus on which items are included in this category, but, in general, they include:

References

  1. ^ "antineop". http://faculty.swosu.edu/scott.long/phcl/antineop.htm. Retrieved 2009-01-24. 
  2. ^ Wiedemann GJ, Robins HI, Gutsche S, Mentzel M, Deeken M, Katschinski DM, Eleftheriadis S, CrahĂŠ R, Weiss C, Storer B, Wagner T. (May 1996). "Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma". European journal of cancer 32A (5): 888–92. PMID 9081372. http://cancerres.aacrjournals.org/cgi/reprint/54/20/5346.pdf. 
  3. ^ Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman AZ, McLennan MT (1946). "Nitrogen mustard therapy. Use of methyl bis (B-chloroethyl)emine hydrochloride and tris (B-chloroethy) amine hydrochloride for Hodgkin's disease lymphosarcoma, leukemia, certain allied and miscellaneous disorders". JAMA 132: 126–132. 
  4. ^ Beverley C. Heinz (2005). Trends in Hodgkin's Disease Research. p. 76. http://books.google.com/books?&ct=result&id=wDS_iYHWq40C. 
  5. ^ McClean S, Costelloe C, Denny WA, Searcey M, Wakelin LP (June 1999). "Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards". Anticancer Drug Des. 14 (3): 187–204. PMID 10500495. 
  6. ^ a b Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach. 11 ed. 2008.
  7. ^ Cruet-Hennequart S, Glynn MT, Murillo LS, Coyne S, Carty MP (April 2008). "Enhanced DNA-PK-mediated RPA2 hyperphosphorylation in DNA polymerase eta-deficient human cells treated with cisplatin and oxaliplatin". DNA Repair (Amst.) 7 (4): 582–96. doi:10.1016/j.dnarep.2007.12.012. PMID 18289945. http://linkinghub.elsevier.com/retrieve/pii/S1568-7864(08)00003-7. 
  8. ^ Armand JP, Ribrag V, Harrousseau JL, Abrey L (June 2007). "Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors". Ther Clin Risk Manag 3 (2): 213–24. PMID 18360630. 
  9. ^ Yasko, Joyce M.; Kirkwood, John M.; Lotze, Michael T. (1998). Current cancer therapeutics. Edinburgh: Churchill Livingstone. pp. 3. ISBN 0-443-06527-6. 
  10. ^ Schmit-Neuerburg, Klaus-Peter; Reiner Labitzke (2000). Manual of Cable Osteosyntheses: History, Technical Basis, Biomechanics of the Tension Band Principle, and Instructions for Operation. Berlin: Springer. pp. 166. ISBN 3-540-66508-0. 
  11. ^ Bailey, Christopher J.; Corner, Jessica (2001). Cancer nursing: care in context. Oxford: Blackwell Science. pp. 214. ISBN 0-632-03998-1. 
  12. ^ Kutner, Jean S; Gonzales, Ralph (2006). Current Practice Guidelines in Primary Care: 2007 (Current Practice Guidelines in Primary Care). McGraw-Hill Professional. pp. 118. ISBN 0-07-147781-0. 
  13. ^ Pizzo, Philip A.; Poplack, David G. (2006). Principles and practice of pediatric oncology. Hagerstwon, MD: Lippincott Williams & Wilkins. pp. 313. ISBN 0-7817-5492-5. 

External links

Retrieved from "http://en.wikipedia.org/wiki/Alkylating_antineoplastic_agent"

Adobe Acrobat Document Download Adobe Acrobat (pdf) files


[pdf] Alkylating antineoplastic agent
If a protocol specifies the agent\'s action the agent does not need to deliber ... not applicable or leave a number of alternatives open then the agent needs ...
[pdf] Alkylating antineoplastic agent
We describe in detail an implementation of Dynamic Agent Compression that is ... Considering Agent Attributes as Data. Compression algorithms are ...
[pdf] Alkylating antineoplastic agent
A mobile agent is a running program that can move from. host to host ... A mobile agent runs in one location, moves (with. its state) to another host, and ...
[pdf] Alkylating antineoplastic agent
In this paper, we report some results from modelling tax agent behavior ... ables included descriptive and summary statistics of tax agent practice, such ...
[pdf] Alkylating antineoplastic agent
There is an increasing interest in agent-oriented technology, spanning applications as diverse as information ... agent and the main research areas in agent technology. ...
[pdf] Alkylating antineoplastic agent
This page describes the JON Agent that ships with JBoss Operations Network 2.0. ... with 1.x. The new agent is more configurable, performs better and ...
[pdf] Alkylating antineoplastic agent
of the mobile agent migration itinerary has a large impact on. the performance of ... erally speaking, a mobile agent is a special kind of software ...
[pdf] Alkylating antineoplastic agent
Each agent consists of a functional body (usually a stand–alone ... To add an agent to a multi-agent system it is necessary to use a communication ...
[pdf] Alkylating antineoplastic agent
time, Soufan was the only F.B.I. agent. in the city who spoke Arabic, ... young agent as a "national treasure." De- spite Soufan\'s youth and his relatively. short ...
[pdf] Alkylating antineoplastic agent
The Sophos Compliance Agent is a configurable application that ... Quarantine Agent also limits the endpoint to quarantined areas of the corporate ...

Show more pdf files...
Powerpoint Documents Download Powerpoint slide (ppt) files
[ppt] Alkylating antineoplastic agent
Amedeo\'s agent evaluates the meeting relevance and decides that Amedeo is not ... A mixed-initiative agent-based system is a user-agent pair in which the decision ...
[ppt] Alkylating antineoplastic agent
An agent-oriented programming language that extends Java with agent concepts. ... Efficiency: modular agent approach allows quick and easy implementation of new ...
[ppt] Alkylating antineoplastic agent
An agent is anything that can be viewed as perceiving its environment through ... "An autonomous agent is a system situated within and a part of an environment ...
[ppt] Alkylating antineoplastic agent
A reactive agent is one that maintains an ongoing interaction with ... The easiest way for an agent to satisfy the agenda is to change only the ...
[ppt] Alkylating antineoplastic agent
The concept of an agent can be traced back to Actor model (Hewitt, 1977) ... Fifth, the visitor hosting agent creates the schedule for the visitor ...
[ppt] Alkylating antineoplastic agent
... where seller hire a estate agent which is responsible for selling his ... Agent Aspects. Seller: Considering the bid – getting highest price (goal) Buyer: ...
[ppt] Alkylating antineoplastic agent
an agent carries out a task in favor of someone who has delegated it ? ... "An agent is anything that can be viewed as perceiving its environment through ...
[ppt] Alkylating antineoplastic agent
Rational behavior = an agent prefers a greater utility (payoff) over a smaller ... IR of an agent participation = The agent\'s payoff in the negotiated solution is ...
[ppt] Alkylating antineoplastic agent
An agent is a computer system, situated in some environment, that is capable of ... adaptability, but those given here are the distinguishing features of an agent. ...
[ppt] Alkylating antineoplastic agent
Framework of the Transaction Agent System with Logical Modeling ... Control (agent) activities (b) Planning and organizing activities: (agent community ...

Show more powerpoint files...
Download Powerpoint slide (ppt) files


[msword] Alkylating antineoplastic agent
Authorized patrons who require an Agent or Assistant for shopping at ... be mailed a letter authorizing the Agent/Assistant to shop at the NEX/Commissary ...
[msword] Alkylating antineoplastic agent
Typically, when the word "agent" is used, many people conjure up images from Web ... a summary of how agent-based technology is currently being employed. ...
[msword] Alkylating antineoplastic agent
Export program has a new functionality called "Agent Settlement" ... The agent\'s profit percent and profit service code should be set in the Overseas ...
[msword] Alkylating antineoplastic agent
Meteor Authentication Agent will attempt to verify the identity of ... Meteor Authentication Agent agrees to provide 30 days advance notice of a change ...
[msword] Alkylating antineoplastic agent
Becoming an official agent for Language Link. If you decide that you ... to appoint The Agent, who is hereby authorised to enrol students on behalf of ...
[msword] Alkylating antineoplastic agent
Certainly the SDR does not hold the agent responsible for these agent balances? ... The agent can make a partial payment of the undisputed owed agent commissions ...
[msword] Alkylating antineoplastic agent
The EDUCATION PROVIDER will direct the AGENT to a copy of the Code of Practice ... The AGENT shall advise, evaluate and screen all prospective students ...
[msword] Alkylating antineoplastic agent
Control: the principal must have the right to control the agent by ... Did the agent intend to benefit the principal? If the agent even in part intended to ...
[msword] Alkylating antineoplastic agent
This thesis concerns one such solution, called generative agent migration. ... There the agent is regenerated using the blueprint. This thesis ...
[msword] Alkylating antineoplastic agent
A GUI-Builder agent then uses these properties to construct the ... Thus, the agent developer with little Swing experience is forced to spend a ...

Show more ms word files...
Top